Mouse IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT655-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Ziyu Wen A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine Hum Vaccin Immunother 2023 19 2171233
Wenming Liu A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine Emerg Microbes Infect 2023 12 2233643
Piyush Dravid Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection PLoS Pathog 2023 19 e1011697
Xuejie Liu A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses NPJ Vaccines 2023 8 132
Ziyu Wen Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice Viruses 2023 15
Chengjin Ye Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission Microbiol Spectr 2023 11 e0065323
Chia-Hung Chen A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy J Exp Clin Cancer Res 2023 42 29
Anna D'Alise Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer Front Immunol 2023 14 1156714
Michael McGee Evolutionary conservation and positive selection of influenza A nucleoprotein CTL epitopes for universal vaccination J Med Virol 2022 94 2578-2587
Minchao Li Comparison of the Immunogenicity of HIV-1 CRF07_BC Gag Antigen With or Without a Seven Amino Acid Deletion in p6 Region Front Immunol 2022 13 850719